Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection - Université de Lorraine Access content directly
Journal Articles JAMA Ophthalmology Year : 2015

Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection

Fred Poordad
  • Function : Author
  • PersonId : 940981
Michael A. Bennett
  • Function : Author
  • PersonId : 980173
James Levin
  • Function : Author
Thomas Sepe
  • Function : Author
Edward Tam
  • Function : Author
Victor de Ledinghen

Dates and versions

hal-01679637 , version 1 (10-01-2018)

Identifiers

Cite

Fred Poordad, William Sievert, Lindsay Mollison, Michael A. Bennett, Edmund Tse, et al.. Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection. JAMA Ophthalmology, 2015, 313 (17), pp.1728-1735. ⟨10.1001/jama.2015.3860⟩. ⟨hal-01679637⟩
96 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More